In her final CND as IDPC ED, Ann Fordham reflects on a historic shift: the recognition of harm reduction in UN drug policy debates, amid rising geopolitical tensions, fractured consensus, and a multilateral system under strain.
IDPC and 12 civil society organisations warn about the growing weaponisation of 'narcoterrorism' narratives to justify extrajudicial killings and unlawful military operations, in violation of international human rights law.
IDPC considers Resolution 60/26 a landmark affirmation of the Council’s authority to address the human rights implications of drug policy, strengthening the role of the UN human rights system and reinforcing calls for health-, rights- and evidence-based drug policies globally.
EHRA and partners analyse how shrinking civic space and punitive legal frameworks are undermining community-led HIV and TB responses in the region, directly impacting LGBTQI+ people, people who use drugs, sex workers, and people living with HIV.
Punitive drug laws are fuelling corruption, strengthening illicit markets and misdirecting police resources, while failing to improve community safety.
The European Commission’s proposed 2026–2030 EU Drugs Strategy shifts emphasis toward enforcement and border control, prompting calls to prioritise harm reduction, housing, community-based care and rights-based approaches.
Ten years after the 2016 UNGASS, punitive drug policies remain dominant globally, with human rights violations, rising deaths and shrinking civic space undermining promises of reform.
